News from Pharmaceutical Executive:
Feature spotlights both drug companies' digital marketing initiatives for getting their name out to patient and physician community; winning companies to be honored at CBI's iPharma 2014 summit NEW YORK, May 8, 2014 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE magazine's May cover story http://www.pharmexec.com/pharmexec/Top+Feature/2014-Brand-of-the-Year/ArticleStandard/Article/detail/842582 and the interactive eBook "iDigital Marketing Winning Brands," available for free in the iTunes […]
Winners include Teva's Coxapone, a specialty drug for the treatment of chronic disease, and Corcepts' KORLYM, an orphan drug for a rare condition NEW YORK, May 7, 2014 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE magazine's June cover story and the magazine's "iDigital Marketing Winning Brands," an interactive eBook available for free in the iTunes Store https://itunes.apple.com/us/app/pharma-sci/id568221918?mt=8 features the […]
NEW YORK, Feb. 11, 2014 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE, the biopharmaceutical industry's premier publication,spoke with leaders in a resurgent patient movement about matters of life and death: compassionate use access to new drugs, clinical trial participation policy, and the individual unmet needs of patients suffering from dementia and cancer. Pleas for compassionate use access are on the […]
Report focuses on Obamacare, BRIC markets, and "new medical culture" NEW YORK, Feb. 5, 2014 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE, the biopharmaceutical industry's premier publication,presents the 2014 INDUSTRY OUTLOOK, its annual review of the business and policy environment for Big Pharma. Will 2014 be a year of compromise and collaboration — or will it be one of retreat […]
October issue detects source of success as pricing power, depending on company's ability to come in first with a new indication or offer compelling unique value proposition that payers will accept NEW YORK, Oct. 17, 2013 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE, the biopharmaceutical industry's premier publication, highlights the 2013 Annual Audit of biopharmaceutical companies that deliver the most […]
Profiles, photos and behind-the-scenes interviews show how these leaders are uniquely poised to change pharmaceutical industry NEW YORK, July 30, 2013 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE, the biopharmaceutical industry's premier publication, celebrates 15 winners in its annual "Emerging Pharma Leaders" competition on the cover of its July issue. The 15 new trendsetters, in many ways, reflect an […]
Pharma50 includes cover feature along with exclusive data, charts and performance tracking within pharmaceutical industry NEW YORK, May 30, 2013 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE magazine's May cover ranks Pharma's 50 top global pharmaceutical companies by revenues and examines five trends that shape current sales performance across the geographies where the pharma group competes. For the thirtieth […]
Merck's Bridgette P. Heller receives cover feature, exclusive behind-the-scenes interview and photographs NEW YORK, May 1, 2013 /PRNewswire/ — PHARMACEUTICAL EXECUTIVE magazine's April cover story profiles Bridgette P. Heller, executive vice president at Merck, president of Merck Consumer Care and the Healthcare Businesswomen's Association (HBA) 2013 Woman of the Year. For the sixth year in a row, […]
NEW YORK, March 26, 2013 /PRNewswire/ — Pharmaceutical Executive, the monthly magazine and daily online publication of record on analytics, trends and personalities in the biopharmaceutical industry worldwide, announced today the choice for its 2013's drug Brand of the Year: Merck's Januvia [sitagliptin], a first in class dipeptide peptidase-4 inhibitor treatment for adult onset [Type II] […]
